Skip to Content
Merck
CN
  • Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Nature chemical biology (2009-09-08)
Jing Yuan, Ronald L Johnson, Ruili Huang, Jennifer Wichterman, Hongying Jiang, Karen Hayton, David A Fidock, Thomas E Wellems, James Inglese, Christopher P Austin, Xin-zhuan Su
ABSTRACT

Studies of gene function and molecular mechanisms in Plasmodium falciparum are hampered by difficulties in characterizing and measuring phenotypic differences between individual parasites. We screened seven parasite lines for differences in responses to 1,279 bioactive chemicals. Hundreds of compounds were active in inhibiting parasite growth; 607 differential chemical phenotypes, defined as pairwise IC(50) differences of fivefold or more between parasite lines, were cataloged. We mapped major determinants for three differential chemical phenotypes between the parents of a genetic cross, and we identified target genes by fine mapping and testing the responses of parasites in which candidate genes were genetically replaced with mutant alleles. Differential sensitivity to dihydroergotamine methanesulfonate (1), a serotonin receptor antagonist, was mapped to a gene encoding the homolog of human P-glycoprotein (PfPgh-1). This study identifies new leads for antimalarial drugs and demonstrates the utility of a high-throughput chemical genomic strategy for studying malaria traits.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Pyrocatechol, ≥99%
Sigma-Aldrich
Promethazine hydrochloride
Sigma-Aldrich
Retinoic acid, ≥98% (HPLC), powder
Sigma-Aldrich
(±)-Verapamil hydrochloride, ≥99% (titration), powder
Sigma-Aldrich
R(+)-3-(3-Hydroxyphenyl)-N-propylpiperidine hydrochloride, solid
Sigma-Aldrich
Palmitoylethanolamide
Sigma-Aldrich
S-(4-Nitrobenzyl)-6-thioinosine, ≥98%, solid
Sigma-Aldrich
N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride
Sigma-Aldrich
D-erythro-Dihydrosphingosine, ≥98%
Supelco
(−)-Cotinine solution, drug standard, 1.0 mg/mL in methanol
Sigma-Aldrich
8-Bromoadenosine 3′,5′-cyclic monophosphate sodium salt, ≥97% (HPLC), powder
Sigma-Aldrich
Imipramine hydrochloride, BioXtra, ≥99% (TLC)
Sigma-Aldrich
Riluzole, solid
Sigma-Aldrich
Chloroquine diphosphate salt, powder or crystals, 98.5-101.0% (EP)
Sigma-Aldrich
Decamethonium bromide, crystalline
Sigma-Aldrich
Progesterone, ≥99%
Sigma-Aldrich
Nortriptyline hydrochloride, ≥98% (HPLC), powder
Sigma-Aldrich
Quinacrine dihydrochloride, ≥90%
Sigma-Aldrich
Naltrexone hydrochloride
Sigma-Aldrich
Pancuronium bromide
Sigma-Aldrich
(S)-(+)-Camptothecin, ≥90% (HPLC), powder
Sigma-Aldrich
Fluorouracil, meets USP testing specifications
Sigma-Aldrich
R(+)-SCH-23390 hydrochloride, ≥98% (HPLC), solid
Sigma-Aldrich
5-Fluorouracil, ≥99% (HPLC), powder
Sigma-Aldrich
Aurintricarboxylic acid, practical grade, ≥85% (titration), powder
Sigma-Aldrich
Metoclopramide hydrochloride, solid
Sigma-Aldrich
Dopamine hydrochloride
Sigma-Aldrich
Quipazine maleate salt
Sigma-Aldrich
(±)-6-Chloro-PB hydrobromide, ≥98% (HPLC), solid
Sigma-Aldrich
Homovanillic acid, Fluorimetric reagent